Sudhir V. Shah, MD; Vashu Thakur, MD
This content is PDF only. Please click on the PDF icon to access.
To the Editor: Recent studies have begun to delineate the pathophysiologic basis for the syndrome of pregnancy-associated diabetes insipidus that begins during gestation and remits after delivery (1, 2, 3). Barron and colleagues (1) described three cases of diabetes insipidus resistant to arginine vasopressin ("vasopressin-resistant diabetes insipidus of pregnancy") in pregnant women. On the basis of knowledge that placenta generates vasopressinase (4), an aminopeptidase that degrades arginine vasopressin, Barron and colleagues, as well as other researchers, have suggested that excessive production of vasopressinase may be responsible for pregnancy-associated diabetes insipidus in some patients. In a recent report, Durr and colleagues
Shah SV, Thakur V. Vasopressinase and Diabetes Insipidus of Pregnancy. Ann Intern Med. ;109:435–436. doi: 10.7326/0003-4819-109-5-435_2
Download citation file:
Published: Ann Intern Med. 1988;109(5):435-436.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use